Breaking News
Sort by:
Top Post
Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring
Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces […]
Evonetix Granted Patent for Binary Assembly Method for Gene Synthesis
EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it […]
RayCare In Clinical Use With CyberKnife at Swiss Medical Network in Switzerland
RaySearch Laboratories AB (publ) announces that La Clinique Générale-Beaulieu, a part of Swiss Medical Network […]
Limaca Medical Receives FDA Breakthrough Device Designation
Limaca Medical (“Limaca”) announced today that its Precision-GI™ Endoscopic Ultrasound Biopsy Product has received a Breakthrough […]
GenScript Debuts Industry's Highest Throughput DNA Synthesis Platform for Commercial DNA Digital Data Storage
GenScript USA Inc., the world’s leading life science research tools and services provider, announced today the debut […]
Canadian North York General Hospital Chooses Enterprise Imaging Solution from Sectra to Improve Radiology Workflows
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a contract with North […]
Abbott Receives FDA Approval for Aveir™ Vr Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved […]
Healthtech Company Paindrainer AB Recruits New CEO with Experience from Commercialization of Digital Services
Erik Frick is taking over as new CEO of PainDrainer AB with the task of […]
Arrayjet Introduces Mercury Range of Next-generation Microarray Printers
Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of […]
Dexcom ONE on NHS Prescription Following NICE Diabetes Guidelines
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more